InvestorsHub Logo
Followers 14
Posts 773
Boards Moderated 0
Alias Born 06/21/2015

Re: Antbird post# 108049

Monday, 11/19/2018 5:10:16 PM

Monday, November 19, 2018 5:10:16 PM

Post# of 205097
Hey Antbird, thanks for the response! As far as which department to approach about this deal, I would think of the following I would ask myself:

Program Manager for Allergy Department: Ask specifics of how the test is presented as an option for patients

Lab Department: Since our organizations already have our own CLIA licensed labs - do we purchase the processing equipment from Arrayit to do the analysis ourselves or do we still depend on the patients to send the cards to Arrayit's lab? Either way, I just don't think Arrayit's lab will be able to handle the massive amounts of blood cards that come in from our millions of patients. I would think our organizations would purchase the equipment and training (ie $$$$$) from Arrayit to be able to process the blood cards on our own. This is something I hope longs are thinking about as well.

Department of infectious diseases: if Sutter is committed to IgE blood card testing with Arrayit - does that open doors to Arrayit's other diagnostic products? Why was a deal signed prior to FDA approvals? Does Sutter know something we don't? :)

I will be on and off from IHUB. I can't stand the constant complainers who can't see the big picture. Have a great Thanksgiving Antbird